MTF Biologics and Kolosis BIO launched DBX Fiber, the latest addition to the DBX portfolio, according to a March 31 news release.
The DBX Fiber is a fiber tissue form processed to provide surgeons with superior handling and osteoinductive potential. Kolosis’ partnership with MTF Biologics is helping expand the DBX suite of products which includes DBX Mix and DBX Putty.
“Kolosis continues to strengthen its position as the leading pure-play orthobiologics provider in spine and orthopedics, and the addition of DBX Fiber is another important step in expanding our portfolio,” Collin Begley, CEO of Kolosis, said in the release. “Through our partnership with MTF Biologics, we’re able to expand the DBX family with a fiber format that offers surgeons greater versatility while continuing to deliver the trusted biologics solutions they rely on.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
